OUR MISSION: The Kentucky LEADS Collaborative is dedicated to reducing the burden of lung cancer in Kentucky and beyond through development, evaluation, and dissemination of novel, community-based interventions to promote provider education, survivorship care, and prevention and early detection regarding lung cancer.
Latest blog post
Introducing the Kentucky LEADS Collaborative
What is the Kentucky LEADS Collaborative? Principal Investigator Jamie Studts, PhD explains the mission of the Collaborative in this brief video.
Events
Register and attend the 2017 National Advocacy Summit!
Webinar on Lung Cancer Screening Set for March 8
November 2016 Lung Cancer Awareness Month Events in Kentucky
2016 Central Kentucky Free to Breathe Run/Walk
2016 Shine A Light Events in Kentucky
Kentucky LEADS at the statewide meeting of the Kentucky Cancer Program Regional Cancer Coordinators
Shine A Light events in Kentucky
5th Annual Lung Cancer 5K Run/Walk and 1-Mile Walk
There is no doubt that lung cancer screening decisions are complicated. Recent data reported by our colleagues at the University of Louisville showed suboptimal uptake of screening. In this commentary, Dr. Lin explores some additional concerns about lung cancer screening. What do you think? How can we improve implementation of lung cancer screening in ways that reduces harms and maximizes benefits?
www.medscape.com/viewarticle/897205
Are PCPs Really Doing a Bad Job of Screening for Lung Cancer?
medscape.com
Lung cancer screening rates in the United States are low. Is that necessarily bad?Our wonderful partners at the Lung Cancer Alliance have announced their 10th Anniversary Advocacy Summit to be held in Washington, DC (July 10-12). This is an amazing event dedicated to supporting lung cancer advocacy and support.
With the low-dose CT, catching lung cancer early is possible. Know your risk factors and ask about getting tested. bit.ly/2GlKQPH
The USPSTF announced today the start of a plan to review the lung cancer screening guidelines. The first step is to solicit comments on the Draft Research Plan, and the commenting period is open now.
www.uspreventiveservicestaskforce.org/Page/Document/draft-research-plan/lung-cancer-screening1
Draft Research Plan: Lung Cancer: Screening - US Preventive Services Task Force
uspreventiveservicestaskforce.org
This is a webpage on the US Preventive Services Task Force USPSTF siteThe good news continues to come in with regard to lung cancer prevention, early detection, treatment, and survivorship. Hopefully these expanded options can help change how we view lung cancer, both individuals at-risk and those who have been diagnosed.
#lungcancersurvivorsarecancersurvivors
www.cancer.gov/news-events/cancer-currents-blog/2018/pembrolizumab-lung-cancer-first-line?cid=eb_...
Immunotherapy Expands Lung Cancer Treatment Options
cancer.gov
Results from a large clinical trial show combining the immune checkpoint inhibitor pembrolizumab (Keytruda) with chemotherapy helped some patients with advanced cancer live longer. As this Cancer Currents post explains, the results will immediately affect patient care.